Miracle Mile Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.3M | Buy |
18,319
+5,043
| +38% | +$3.93M | 0.24% | 77 |
|
2025
Q1 | $11M | Sell |
13,276
-37
| -0.3% | -$30.6K | 0.22% | 76 |
|
2024
Q4 | $10.3M | Buy |
13,313
+6,294
| +90% | +$4.86M | 0.21% | 77 |
|
2024
Q3 | $6.22M | Buy |
7,019
+609
| +10% | +$540K | 0.14% | 95 |
|
2024
Q2 | $5.8M | Buy |
6,410
+667
| +12% | +$604K | 0.14% | 96 |
|
2024
Q1 | $4.47M | Buy |
5,743
+600
| +12% | +$467K | 0.11% | 117 |
|
2023
Q4 | $3M | Buy |
5,143
+489
| +11% | +$285K | 0.08% | 143 |
|
2023
Q3 | $2.5M | Buy |
4,654
+27
| +0.6% | +$14.5K | 0.08% | 154 |
|
2023
Q2 | $2.17M | Sell |
4,627
-400
| -8% | -$188K | 0.07% | 174 |
|
2023
Q1 | $1.73M | Buy |
5,027
+94
| +2% | +$32.3K | 0.06% | 209 |
|
2022
Q4 | $1.8M | Buy |
4,933
+693
| +16% | +$254K | 0.06% | 209 |
|
2022
Q3 | $1.37M | Buy |
4,240
+2,243
| +112% | +$725K | 0.06% | 176 |
|
2022
Q2 | $647K | Buy |
1,997
+473
| +31% | +$153K | 0.03% | 268 |
|
2022
Q1 | $437K | Sell |
1,524
-14,704
| -91% | -$4.22M | 0.02% | 337 |
|
2021
Q4 | $4.48M | Buy |
16,228
+101
| +0.6% | +$27.9K | 0.17% | 107 |
|
2021
Q3 | $3.73M | Sell |
16,127
-84
| -0.5% | -$19.4K | 0.18% | 113 |
|
2021
Q2 | $3.72M | Sell |
16,211
-1,638
| -9% | -$376K | 0.2% | 100 |
|
2021
Q1 | $3.33M | Sell |
17,849
-694
| -4% | -$130K | 0.19% | 104 |
|
2020
Q4 | $3.13M | Buy |
18,543
+447
| +2% | +$75.5K | 0.19% | 110 |
|
2020
Q3 | $2.68M | Buy |
18,096
+3,226
| +22% | +$478K | 0.19% | 111 |
|
2020
Q2 | $2.44M | Buy |
+14,870
| New | +$2.44M | 0.2% | 108 |
|